References
- Majumder P.L., Sen R.C. Moscatilin, a bibenzyl derivative from the orchid dendrobrium moscatum. Phytochemistry 1987; 26: 2121–2125
- Hsu H.Y., Chen Y.P., Sheu S.J., Hsu C.S., Chen C.C., Chang H.C. Oriental Materia Medica—a Concise Guide. Oriental Healing Arts Institute, Los Angeles 1986; p. 582
- Chen C.C., Wu L.G., Ko F.N., Teng C.M. Antiplatelet aggregation principles of Dendrobrium loddigesii. J. Nat. Prod. 1994; 57: 1271–1274
- King R.W., Jackson P.K., Kirschner M.W. Mitosis in transition. Cell 1994; 79: 563–571
- Togoshima F., Moriguchi T., Wada A., Fukuda M., Nishida E. Nuclear export of cyclin B1 and its possible roles in the DNA damages-induced G2 checkpoint. EMBO J. 1998; 17: 2728–2735
- Atherton F.S., Packen L.L., Geahlen R.L., Piwnica-Worms H. Mechanisms of P34 cdc 2 regulation. Mol. Cell. Biol. 1993; 13: 1585–1675
- Ho C.K., Wang C.C., Li S.Y., Chiang H., Yu K.J., Wang S.Y. Characterization of a human tumorigenic poorly differentiated trophoblast cell line. In Vitro 1994; 30A: 415–417
- Lin J.H., Tong M.J., Stevenson D. A new human hepatocellular carcinoma cell line secreting hepatitis B surface antigen and alpha-fetoprotein (abstr). Viral Hepatitis and Liver Disease, G.N. Vyas, J.L. Dienstag, J.H. Hoofragle. Orlando, Grune & Atralton 671. 1984
- Chang C., Lin Y., O-Lee T.W., Chou C.K., Lee T.S., Liu T.J., P'eng F.K., Chen T.Y., Hu C.P. Induction of plasma protein secretion in a newly established human hepatoma cell line. Mol. Cell. Biol. 1983; 2: 1133
- Taki T., Ishikawa H., Imai K., Yachi A., Matsumoto M. Immunological analysis of glycolipids on cell surfaces of cultured human tumor cell lines: expression of lactoneotetrasylcaramide on tumor cell surfaces. J. Biochem. 1985; 98: 887–895
- Baba M., Hasegawa H., Nakayaba M., Shimiza N., Suzuki S., Kamada N., Tani K. Establishment and characterization of a gastric cancer cell line (HUGC-00HIRA) producing high levels of G-CSF, GM-CSF and IL-6: the presence of autocrine growth control by G-CSF. Am. J. Hematol. 1995; 49: 207–215
- Mosmann T. A rapid colorimetric assay for cellular growth and cytotoxicity assays. J. Immunol. Methods 1983; 65: 55–63
- Ongkeko W., Ferguson D.J.P., Harris A.L., Norbury C. Inactivation of cdc 2 increases the level of apoptosis induced by DNA damage. J. Cell Sci. 1995; 108: 2897–2904
- Tsao Y.P., D'Arpa P., Lui L.F. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered of p34cdc2/cyclin B. Cancer Res. 1992; 52: 1823–1829
- Lock R.B. Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Cancer Res. 1992; 52: 1817–1822
- Meijer L., Borgne A., Mulner O., Chong J.P.J., Blow J.L., Inagaki N., Inagaki M., Deleros J., Moulinoux J. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc 2, cdk 2 and cdk 5. Eur. J. Biochem. 1997; 243: 527–536
- Bojanowski K., Nishio K., Fukuda M., Larsen A.K., Saijo N. Effect of suramin on p34cdc 2 kinase in vitro and in extracts from human H69 cells. Evidence for a double mechanism of action. Biochem. Biophys. Res. Commun. 1994; 203: 1574–1580
- Godbois D.M., Hamgachi J.R., Swank R.A., Bradburg E.M. Staurosporine is a potent inhibitor of p34cdc 2 and p34cda 2-like kinases. Biochem. Biophys. Res. Commun. 1992; 184: 80–85
- Losiewicz M.D., Carlson B.A., Kaur G., Sausville E.A., Worland P.J. Potent inhibition of cdc 2 kinase activity by the flavonoid L86-8275. Biochem. Biophys. Res. Commun. 1994; 201: 589–595
- Estamen A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 1990; 2: 275–280